End of life distress as an economic issue: The case for psychedelic-assisted therapy - ERRATUM.

Palliat Support Care March 10, 2026 DOI: 10.1017/s1478951526101771 (opens in new tab) via PubMed Central

Study at a glance

Characteristics	Peer reviewed

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

End of life distress as an economic issue: The case for psychedelic-assisted therapy. Palliat Support Care January 28, 2026 via PubMed Central
Psychedelic-assisted psychotherapy for existential suffering: Facilitating self-transcendence at the end of life. The International Journal of Transpersonal Studies March 18, 2022
Psychedelic therapy at the end of life: unexplored alternative to assisted suicide in the UK. The British journal of psychiatry : the journal of mental science July 14, 2026 via PubMed
Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care. Neuropharmacology September 15, 2022 69 citations via PubMed
Barriers and Facilitators to the Equitable Access of Psychedelic Medical Care and Research in Alzheimer’s Disease and Related Dementias AJOB Neuroscience April 3, 2023 via Semantic Scholar

Comments

No comments yet.

Study at a glance

Abstract

Related reading

Comments